Ruplizumab
Modify Date: 2024-02-24 10:07:05
Ruplizumab structure
|
Common Name | Ruplizumab | ||
|---|---|---|---|---|
| CAS Number | 220651-94-5 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RuplizumabRuplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research[1]. |
| Name | Ruplizumab |
|---|---|
| Synonym | More Synonyms |
| Description | Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |
| RUPLIZUMAB |